Skip to content

Molecular Mechanism of Neutrophil Necroptosis and Its Roles in RA Pathogenesis

Molecular Mechanism of Neutrophil Necroptosis and Its Roles in RA Pathogenesis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02385331
Acronym
MMNNIRP
Enrollment
30
Registered
2015-03-11
Start date
2015-03-31
Completion date
2016-02-29
Last updated
2015-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Neutrophils, necroptosis, apoptosis

Brief summary

Neutrophils play a central role in innate immunity and are rapidly recruited to sites of infection and injury. Neutrophil apoptosis and necroptosis are essential for the inflammatory.This study is designed to investigate the cells and the molecular mechanisms of neutrophil necroptosis and apoptosis.

Detailed description

Necrosis has recently been demonstrated to be programmatic and energy comsuming, a process termed necroptosis. In this project, the investigators aim to investigate the mechanisms and the effects ofneutrophil necroptosis and apoptosis: 1. to investigate the cells and the molecular mechanisms that induce neutrophil necroptosis or delay apoptosis, mainly focusing on the roles of HMGB-1,TNF-α and LPS, 2. to illustrate the effects of some molecules such as TLR, TNFR, RIP1/RIP3, Caspase8, ATP and ROS in the process of sigal transduction and membrane damage during necroptosis or apoptosis , 3. to identify the similarities and differences between traditional necrosis and necroptosis in the aspects of morphologigical changes and inflammatory cytokine release, 4. to find out the effects and mechanisms of neutrophil necroptosis or apoptosis in a rheumatoid arthritis mouse model and the therapeutic effect of blocking one or several pathways in the pathogenesis of rheumatoid arthritis. This study will not only unravel the mechanisms of neutrophil necroptosis and apoptosis, elucidate its roles and significances in inflammation and infection, but also shed new light on anti-inflammatory and anti-infection therapy.

Interventions

None listed

Sponsors

The Third Affiliated Hospital of Southern Medical University
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy Volunteers * age 18-65.

Exclusion criteria

* Don't agree with informed consent

Design outcomes

Primary

MeasureTime frame
The apopotosis and necroptosis of Neutrophils6 months

Countries

China

Contacts

Primary Contacthongyu Jie, doctor
jiehongyu1987@163.com+86 13580508674
Backup Contactew Sun, doctor
ewsun@263.net+86 020-62784421

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026